Intra-Abdominal Infections: Clinical Trials

16 trials for Intra-Abdominal Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 2 recruiting, 2 withdrawn, 1 not yet recruiting. 2 Phase 2, 2 Phase 3, 2 Phase 4, 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Phase 32Completed 1, Not yet recruiting 1
Phase 42Completed 1, Recruiting 1
Not applicable1Withdrawn 1
Phase 11Recruiting 1

Follow Intra-Abdominal Infections: new trials by email Literature Review of Intra-Abdominal Infections trials Research Report on Intra-Abdominal Infections

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Gelaspan vs Crystalloid Therapy in Sepsis
Balanced Gelatin Solution, Acetate Ringer's Solution - Sepsis, Intra-Abdominal Infections
Phase 4RecruitingShanghai Zhongshan Hospital3182026-02-132026-03-20
Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers
JKN2501, Placebo - Bacterial Infections, Urinary Tract Infections
Phase 1RecruitingJoincare Pharmaceutical Group Industry Co., Ltd662025-08-222025-10-03
Capillary Leak Index as a Prognostic Indicator for Post-Operative Abdominal Sepsis in Critically Ill Patients
Intra-Abdominal Infections, Intestinal Obstruction
CompletedAin Shams University1002025-03-042025-12-24
Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAI
Meropenem and Pralurbactam, Saline, Ceftazidime-avibactam - Intra-abdominal Infections
Phase 3Not yet recruitingQilu Pharmaceutical Co., Ltd.7862024-10-312024-10-09
Sepsis Prognosis and Diagnosis in the Emergency Department (SPEED)
IMX-BVN-4 and IMX-SEV-4 - Respiratory Tract Infections, Urinary Tract Infections
WithdrawnInflammatix2022-12-012023-12-27
Gut Microbiota Analysis in IAI Patients With Sepsis-associated Liver Dysfunction
Gut microbiota Analysis - Gut Microbiota, Intra-abdominal Infections
CompletedChinese Medical Association202022-01-032022-11-28
Procalcitonin Guided Antibiotic Therapy
Procalcitonin-guided antibiotic treatment, Standard of Care Antibiotic Treatment - Intra-Abdominal Infections
Not applicableWithdrawnColumbia University2021-09-012021-10-21
TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis
TriVerity - Respiratory Tract Infections, Urinary Tract Infections
CompletedInflammatix14412020-02-282024-10-22
LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Intra-abdominal Infection (cIAI)
LYS228, Standard of care therapy - Intra-abdominal Infections
Phase 2TerminatedNovartis Pharmaceuticals32018-05-152021-10-11
Abdominal SepsiS Study: Epidemiology of Etiology and Outcome
Intra-Abdominal Infections
CompletedEuropean Society of Intensive Care Medicine22002016-01-012017-06-29
Tygacil Drug Use Investigation
Tigecycline (Tygacil) - Intra-Abdominal Infections, Skin Disease, Infectious
CompletedPfizer1162013-04-152019-02-06
Study of the Safety, Tolerability, and Efficacy of Relebactam (MK-7655) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone to Treat Complicated Intra-Abdominal Infection [cIAI] (MK-7655-004)
Relebactam 250 mg, Relebactam 125 mg, Imipenem/cilastatin - Intra-abdominal Infections
Phase 2CompletedMerck Sharp & Dohme LLC3512012-06-012019-06-10
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care: - Adenovirus, Anesthesia
CompletedDaniel Benjamin35202011-11-012023-09-06
A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection
Metronidazole, Ceftriaxone sodium - Intra-abdominal Infections
Phase 3CompletedPfizer382011-11-012014-01-24
A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections
Doripenem - Infection, Cross Infection
Phase 4CompletedJanssen-Cilag Ltd.,Thailand2702009-06-012013-10-30
Post-Authorization Study Evaluating Safety Of Tigecycline
Tigecycline - Intra-Abdominal Infections, Skin Disease, Infectious
CompletedPfizer1152008-08-012012-02-01

Narrower conditions

Intraabdominal Infections (16)  ·  Infections (6)  ·  Sepsis (6)  ·  Urinary Tract Infections (5)  ·  Respiratory Tract Infections (3)  ·  Soft Tissue Infections (3)  ·  Bacterial Infections (2)  ·  Encephalitis (2)  ·  Skin Diseases, Infectious (2)  ·  Adenoviridae Infections (1)  ·  Anxiety Disorders (1)  ·  Appendicitis (1)  ·  Arrhythmias, Cardiac (1)  ·  Autistic Disorder (1)  ·  Bipolar Disorder (1)

Broader conditions

Infections (10)  ·  Pathologic Processes (7)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Female Urogenital Diseases (6)  ·  Female Urogenital Diseases and Pregnancy Complications (6)  ·  Systemic Inflammatory Response Syndrome (6)  ·  Urogenital Diseases (6)  ·  Inflammation (5)  ·  Male Urogenital Diseases (5)  ·  Respiratory Tract Diseases (5)  ·  Urologic Diseases (5)  ·  Bacterial Infections and Mycoses (3)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Nervous System Diseases (3)

Interventions

Metronidazole (2)  ·  Tigecycline (2)  ·  Alfentanil (1)  ·  Amikacin (1)  ·  Aminocaproic Acid (1)  ·  Bosentan (1)  ·  Cefepime (1)  ·  Ceftriaxone (1)  ·  Cidofovir (1)  ·  Cilastatin, Imipenem Drug Combination (1)  ·  Ciprofloxacin (1)  ·  Clozapine (1)  ·  Doripenem (1)  ·  Fosfomycin (1)  ·  Haloperidol (1)

Sponsors

Pfizer (3)  ·  Inflammatix (2)  ·  Ain Shams University (1)  ·  Chinese Medical Association (1)  ·  Columbia University (1)  ·  Daniel Benjamin (1)  ·  European Society of Intensive Care Medicine (1)  ·  Janssen-Cilag Ltd.,Thailand (1)  ·  Joincare Pharmaceutical Group Industry Co., Ltd (1)  ·  Merck Sharp & Dohme LLC (1)  ·  Novartis Pharmaceuticals (1)  ·  Qilu Pharmaceutical Co., Ltd. (1)  ·  Shanghai Zhongshan Hospital (1)

Countries

China (4)  ·  United States (3)  ·  Belgium (1)  ·  Canada (1)  ·  Egypt (1)  ·  Greece (1)  ·  Israel (1)  ·  Japan (1)  ·  Singapore (1)  ·  Thailand (1)  ·  United Kingdom (1)

Top investigators

Ahmed M Ahmed, MD. (1)  ·  Changhong Miao, MD (1)  ·  Chi Hornik, PharmD (1)  ·  Hanaa A El-Gendy, MD (1)  ·  Katherine Fischkoff, MD (1)  ·  Wenkui Yu, Ph.D. (1)  ·  Yunfei Ju, MM (1)

Results publications

PMID 11172350, PMID 23772042, PMID 23772045, PMID 23772047, PMID 24171518, PMID 24287460, PMID 24614374, PMID 24949994, PMID 25442806, PMID 25887649, PMID 26039810, PMID 26496306, PMID 26677396, PMID 26926644, PMID 27503659, PMID 27522443, PMID 28137820, PMID 28268067, PMID 28290120, PMID 28779462, PMID 29084742, PMID 29271816, PMID 29435949, PMID 29677389, PMID 30061293, PMID 30574564, PMID 30790601, PMID 31317556, PMID 31548185, PMID 31814149, PMID 32324313, PMID 32497307, PMID 33029806, PMID 33406974, PMID 33903114, PMID 34040329, PMID 34302290, PMID 35370711, PMID 35491971, PMID 36186801, PMID 38117435, PMID 38850687, PMID 41247430